title: PGE2 suppresses NK activity in vivo directly and through adrenal hormones: effects that cannot be reflected by ex vivo assessment of NK cytotoxicity.
abstract: Surgery can suppress in vivo levels of NK cell cytotoxicity (NKCC) through various mechanisms, including catecholamine-, glucocorticoid (CORT)-, and prostaglandin (PG)-mediated responses. However, PGs are synthesized locally following tissue damage, driving proinflammatory and CORT responses, while their systemic levels are often unaffected. Thus, we herein studied the role of adrenal factors in mediating in vivo effects of PGs on NKCC, using adrenalectomized and sham-operated F344 rats subjected to surgery or PGE(2) administration. In vivo and ex vivo approaches were employed, based on intravenous administration of the NK-sensitive MADB106 tumor line, and based on ex vivo assessment of YAC-1 and MADB106 target-line lysis. Additionally, in vitro studies assessed the kinetics of the impact of epinephrine, CORT, and PGE(2) on NKCC. The results indicated that suppression of NKCC by epinephrine and PGE(2) are short lasting, and cannot be evident when these compounds are removed from the in vitro assay milieu, or in the context of ex vivo assessment of NKCC. In contrast, the effects of CORT are long-lasting and are reflected in both conditions even after its removal. Marginating-pulmonary NKCC was less susceptible to suppression than circulating NKCC, when tested against the xenogeneic YAC-1 target line, but not against the syngeneic MADB106 line, which seems to involve different cytotoxicity mechanisms. Overall, these findings indicate that elevated systemic PG levels can directly suppress NKCC in vivo, but following laparotomy adrenal hormones mediate most of the effects of endogenously-released PGs. Additionally, the ex vivo approach seems limited in reflecting the short-lasting NK-suppressive effects of catecholamines and PGs.
authors.affiliation: Neuroimmunology Research Unit, Department of Psychology, Tel-Aviv University, Israel.
authors.forename: G
authors.initials: G
authors.lastname: Meron
authors.forename: Y
authors.initials: Y
authors.lastname: Tishler
authors.forename: L
authors.initials: L
authors.lastname: Shaashua
authors.forename: E
authors.initials: E
authors.lastname: Rosenne
authors.forename: B
authors.initials: B
authors.lastname: Levi
authors.forename: R
authors.initials: R
authors.lastname: Melamed
authors.forename: N
authors.initials: N
authors.lastname: Gotlieb
authors.forename: P
authors.initials: P
authors.lastname: Matzner
authors.forename: L
authors.initials: L
authors.lastname: Sorski
authors.forename: S
authors.initials: S
authors.lastname: Ben-Eliyahu
mesh_terms: D000305:Adrenal Cortex Hormones / Q000502:physiology*; D000315:Adrenalectomy; D000818:Animals; D045744:Cell Line, Tumor; D015232:Dinoprostone / Q000502:physiology*; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D005434:Flow Cytometry; D005938:Glucocorticoids / Q000494:pharmacology; D007694:Killer Cells, Natural / Q000187:drug effects / Q000502:physiology*; D007813:Laparotomy / Q000009:adverse effects; D008297:Male; D051381:Rats; D011916:Rats, Inbred F344
chemical_list: D000305:Adrenal Cortex Hormones; D005938:Glucocorticoids; D015232:Dinoprostone; D004837:Epinephrine